Steinhardt, M. J., Cejka, V., Chen, M., Bäuerlein, S., Schäfer, J., Adrah, A., . . . Lund University, F. o. E. (2024). Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study. Journal of Clinical Medicine, 13(1), . https://doi.org/10.3390/jcm13010283
Chicago-referens (17:e uppl.)Steinhardt, Maximilian J., et al. "Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study." Journal of Clinical Medicine 13, no. 1 (2024). https://doi.org/10.3390/jcm13010283.
MLA-referens (9:e uppl.)Steinhardt, Maximilian J., et al. "Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study." Journal of Clinical Medicine, vol. 13, no. 1, 2024, https://doi.org/10.3390/jcm13010283.
